Tag:
Thermo Fisher
Latest Headlines
Latest Headlines
Analytical instruments, specialty diagnostics drive Thermo Fisher Q1 sales
Thermo Fisher Scientific ($TMO) credited high demand for its analytical instruments as helping to drive overall record revenue during its fiscal 2012 first quarter. But the company's specialty diagnostic's segment also grew like gangbusters, as it continued to digest a major 2011 acquisition.
Thermo Fisher done with big deals ... for now
Acquisition-hungry Thermo Fisher Scientific ( $TMO ) is taking it down a notch in 2012. CEO Marc Casper tells Bloomberg that after making 5 acquisitions last year, it will use its cash to pay down its...
Thermo Fisher launches Biomarker Translational Center
A year ago, mass spectrometry experts Thermo Fisher Scientific ( $TMO ) helped launch a new Biomarker Research Center in Tokyo. Now, the company is doing the same thing a little closer to home, with
Thermo Fisher wraps up Phadia buy
Thermo Fisher Scientific ( $TMO ) has completed its previously announced acquisition of Uppsala, Sweden-based Phadia, which has approximately 1,500 employees and had 2010 revenue of roughly $525
Thermo Fisher to build new Chinese facility
Just like many of their pharma brethren, medical devicemakers are flocking to emerging markets, especially China. On Tuesday, Waltham, MA-based Thermo Fisher Scientific announced plans for a new
Thermo Fisher to collaborate on new biomarker research center
The personalized health movement is getting an influential new player in Japan. Thermo Fisher Scientific announced this week it is pairing its know-how in mass spectrometry with the research skills
Lilly unloads trials-supply business to Fisher Clinical
Moving a step closer to its intended operating model, Eli Lilly is jettisoning its in-house clinical trial materials manufacturing, packaging and labeling operations at its technology center in
Thermo Fisher may sweeten offer for Millipore
Anxious to expand into the biotech business, Thermo Fisher Scientific is reportedly considering bumping its $6 billion-plus-debt bid to buy out Millipore. A source close to the buyout talks tells
